WASHINGTON -- Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic ...

The Hepatitis B and C Therapeutics Market has entered a renewed growth cycle in 2024, led by innovative antiviral regimens, ...

The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C.

The ECDC says the region could still meet its testing targets for HIV, but that it will be harder to improve detection for ...

This retrospective cohort study used data from the Veterans Health Administration to assess the association between chronic untreated HCV and incident PDAC and whether different HCV genotypes affect ...

The Australian Government is funding a new hepatitis C awareness campaign to be piloted in Tasmania, as part of national efforts to identify and treat ...

Atea Pharmaceuticals, Inc. ( AVIR) Discusses Next-Generation Hepatitis C Treatment Developments and Clinical Advancements November 13, 2025 10:00 AM EST Jordan Feld Anthony Martinez Nancy Reau Eric ...

Diagnosed with hepatitis B about eight years ago and now in the cirrhosis stage (liver damage), the 49-year-old from Sabah admitted that he was initially disheartened before finding the strength to ...

Enanta Pharmaceuticals recorded a narrower loss as sales rose in its fiscal fourth quarter driven by higher sales of a hepatitis C virus treatment.

Until recently, it was not uncommon for Dr. Jeannie Kelly, a high risk obstetrician at Washington University School of Medicine in St. Louis, to diagnose a pregnant patient with Hepatitis C, then ...

The office surgery center lacked “a handwashing station with the capabilities to sterilize the surgical team members’ hands..

WASHINGTON -- Assessing sustained virological response (SVR) to hepatitis C virus (HCV) therapy at 4 weeks after treatment ...